米国の乳房再建市場規模、シェア、動向分析レポート：製品別、形態別、最終用途別、セグメント別予測、2025～2030年

米国の乳房再建市場の成長と動向

Grand View Research, Inc.の最新レポートによると、米国の乳房再建市場規模は2030年までに16億5,000万米ドルに達すると予測され、2025～2030年にかけてCAGR 6.8％で拡大すると予測されています。

同市場は、再建を希望する乳がんサバイバーの増加、乳がん治療に対する意識の高まり、手術技術の進歩などにより大きな成長を遂げています。さらに、再建手術に保険が適用されること、低侵襲法の採用が増加していることも市場成長に寄与しています。乳房切除術を受ける女性が増え、乳房の見た目を回復させる選択肢を探すようになるにつれて、これらの手術に対する需要は増加の一途をたどっています。

米国の乳房再建市場における新製品の発売とFDAの承認は、技術革新を促進し、安全基準を強化し、臨床転帰を改善することにより、乳房再建の重要な進歩を促進します。2023年10月、Establishment Labsは、米国で初めてFDA認可を受けたMotiva Flora SmoothSilk Tissue Expanderを発表しました。これにより、術後のモニタリングやがん検診に不可欠なMRI検査が妨げられることなく行えるようになります。エスタブリッシュメント・ラボのこの技術革新は、MRI検査を必要とする患者の乳房再建プロセスを合理化する可能性を秘めています。

米国の乳房再建市場は、患者がこの技術をますます好むようになり、組織拡大器への大きなシフトが見られます。組織拡大器は組織拡大器システムとも呼ばれ、乳房再建手術に備えて皮膚や軟部組織を伸展・拡大させるために使用される移植可能な装置です。この技術は、より自然な外観と感触を提供し、回復時間と瘢痕を軽減する能力により人気を博しています。組織拡大器は、乳房切除後に乳房ポケットを拡大し、乳房インプラントを設置できるようにするために使用されます。2段階の拡大器からインプラントへの乳房再建は、米国における乳房再建手術の半分以上を占めています。ここ数十年で、組織拡大技術は著しく進歩しました。

米国の乳房再建市場レポートハイライト

• 製品別では、自然な仕上がり、回復時間の短縮、組織フラップなどの他の選択肢と比較して低リスクであることから、インプラントセグメントが最大の売上シェアで市場を独占しています。
• 形態別では、多くの患者が好む、より豊かで対称的な外観を提供するため、円形セグメントが最大の売上シェアを占めています。
• 最終用途別では、病院が最大の売上シェアを占めています。病院は乳房切除と再建手術を最も多く行っています。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 米国の乳房再建市場の変数、動向、範囲

• 市場系統の展望
  • 補助市場の展望
• 市場力学
  • 市場促進要因分析
  • 市場抑制要因分析
• 米国の乳房再建市場分析ツール
  • 産業分析-ポーターのファイブフォース分析
  • PESTEL分析

第4章 米国の乳房再建市場：製品別、推定・動向分析

• セグメントダッシュボード
• 米国の乳房再建市場の製品変動分析
• 米国の乳房再建市場の規模と動向分析、製品別、2018～2030年
• インプラント
  • シリコン乳房インプラント
  • 生理食塩水乳房インプラント
• 組織拡大器
  • 生理食塩水拡大器
  • エア組織拡大器
• 無細胞真皮マトリックス

第5章 米国の乳房再建市場：形態別、推定・動向分析

• セグメントダッシュボード
• 米国の乳房再建市場の変動分析
• 米国の乳房再建市場の規模と動向分析、形態別、2018～2030年
• ラウンド
• アナトミカル

第6章 米国の乳房再建市場：最終用途別、推定・動向分析

• セグメントダッシュボード
• 米国の乳房再建市場の最終用途変動分析
• 米国の乳房再建市場の規模と動向分析、最終用途別、2018～2030年
• 病院
• 美容クリニック
• 外来手術センター

第7章 競合情勢

• 市場参入企業の分類
• 主要企業プロファイル
  • Mentor Medical Systems（Johnson & Johnson）
  • Allergan, Inc.（AbbVie）
  • Sientra, Inc.（Acquired by Tiger Aesthetics Medical, LLC）
  • Ideal Implant, Inc.（Bimini Health Tech.）
  • Establishment Labs
  • RTI Surgical
  • Integra LifeSciences Corporation

List of Tables

• Table 1 List of secondary sources
• Table 2 List of abbreviation
• Table 3 U.S Breast Reconstruction Market, By Product, 2018 - 2030 (USD Million)
• Table 4 U.S Breast Reconstruction Market, By Shape, 2018 - 2030 (USD Million)
• Table 5 U.S Breast Reconstruction Market, By End Use, 2018 - 2030 (USD Million)
• Table 6 Participant's Overview
• Table 7 Financial Performance
• Table 8 Product Benchmarking
• Table 9 Strategic Initiatives

List of Figures

• Fig. 1 Information Procurement
• Fig. 2 Primary Research Pattern
• Fig. 3 Market Research Approaches
• Fig. 4 Value Chain-Based Sizing & Forecasting
• Fig. 5 Market Formulation & Validation
• Fig. 6 U.S. Breast Reconstruction Market, Market Segmentation
• Fig. 7 Market Driver Analysis (Current & Future Impact)
• Fig. 8 Market Restraint Analysis (Current & Future Impact)
• Fig. 9 Market Opportunity Analysis (Current & Future Impact)
• Fig. 10 Market Challenge Analysis (Current & Future Impact)
• Fig. 11 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
• Fig. 12 Porter's Five Forces Analysis
• Fig. 13 Regional Marketplace: Key Takeaways
• Fig. 14 U.S. Breast Reconstruction Market, for Implants, 2018 - 2030 (USD Million)
• Fig. 15 U.S. Breast Reconstruction Market, for Silicone Breasts Implants, 2018 - 2030 (USD Million)
• Fig. 16 U.S. Breast Reconstruction Market, for Saline Breasts Implants, 2018 - 2030 (USD Million)
• Fig. 17 U.S. Breast Reconstruction Market, for Tissue Expander, 2018 - 2030 (USD Million)
• Fig. 18 U.S. Breast Reconstruction Market, for Saline Expander, 2018 - 2030 (USD Million)
• Fig. 19 U.S. Breast Reconstruction Market, for Air Tissue Expander, 2018 - 2030 (USD Million)
• Fig. 20 U.S. Breast Reconstruction Market, for Acellular Dermal Matrix, 2018 - 2030 (USD Million)
• Fig. 21 U.S. Breast Reconstruction Market, for Round, 2018 - 2030 (USD Million)
• Fig. 22 U.S. Breast Reconstruction Market, for Anatomical, 2018 - 2030 (USD Million)
• Fig. 23 U.S. Breast Reconstruction Market, for Hospitals, 2018 - 2030 (USD Million)
• Fig. 24 U.S. Breast Reconstruction Market, for Cosmetology Clinics, 2018 - 2030 (USD Million)
• Fig. 25 U.S. Breast Reconstruction Market, for Ambulatory Surgical Centers, 2018 - 2030 (USD Million)

U.S. Breast Reconstruction Market Growth & Trends:

The U.S. breast reconstruction market size is anticipated to reach USD 1.65 billion by 2030 and is projected to expand at a CAGR of 6.8% from 2025 to 2030, according to a new report by Grand View Research, Inc. The market is experiencing significant growth due to the increasing number of breast cancer survivors seeking reconstruction, growing awareness about breast cancer treatments, and advancements in surgical techniques. In addition, the availability of insurance coverage for reconstruction procedures and the increasing adoption of minimally invasive methods contribute to market growth. As more women undergo mastectomies and look for options to restore breast appearance, the demand for these procedures continues to rise.

New product launches and FDA approvals in the U.S. breast reconstruction market drive significant breast reconstruction advancements by promoting innovation, enhancing safety standards, and improving clinical outcomes. In October 2023, Establishment Labs announced the FDA clearance of their Motiva Flora SmoothSilk Tissue Expander, the first of its kind to receive FDA clearance in the U.S. The Motiva Flora expander eliminates the use of magnets in the filling port, making it MRI-conditional. It allows unimpeded MRI scans, crucial for post-surgical monitoring and cancer screening. This innovation by Establishment Labs has the potential to streamline the breast reconstruction process for patients who require MRI scans.

The U.S. breast reconstruction market is witnessing a significant shift toward tissue expanders as patients increasingly prefer this technology. Tissue expanders, also known as tissue expander systems, are implantable devices used to stretch and expand the skin & soft tissues in preparation for breast reconstruction surgery. This technology has gained popularity due to its ability to provide a more natural look and feel, as well as reduced recovery time & scarring. Tissue expanders are used to extend the breast pocket following a mastectomy so that a breast implant can be placed. Two-stage expander-to-implant breast reconstruction accounts for more than half of all breast reconstruction surgeries in the U.S. In the last few decades, tissue expansion technology has significantly advanced.

U.S. Breast Reconstruction Market Report Highlights:

• Based on product, the implants segment dominates the market with the largest revenue share owing to their ability to provide natural-looking results, shorter recovery times, and lower risk compared to other options like tissue flaps.
• Based on shape, the round segment dominate the market with the largest revenue share because they offer a fuller, more symmetrical appearance, which many patients prefer.
• Based on end use, the hospitals dominated the market with the largest revenue share. Hospitals perform the highest number of mastectomy and reconstruction surgeries.

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation and Scope
• 1.2. Research Methodology
• 1.3. Information Procurement
• 1.4. Information or Data Analysis
• 1.5. Market Formulation & Validation
• 1.6. Model Details
• 1.7. List of Data Sources

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
• 2.3. Competitive Insights

Chapter 3. U.S. Breast Reconstruction Market Variables, Trends, & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Ancillary Market Outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
    • 3.2.1.1. Growing awareness and acceptability of breast reconstruction among women with breast cancer
    • 3.2.1.2. Increasing number of breast reconstructive procedures
    • 3.2.1.3. Technological advancements
  • 3.2.2. Market Restraint Analysis
    • 3.2.2.1. Complications associated with implants and product recalls
• 3.3. U.S. Breast Reconstruction Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's Five Forces
    • 3.3.1.1. Bargaining power of suppliers
    • 3.3.1.2. Bargaining power of buyers
    • 3.3.1.3. Threat of substitutes
    • 3.3.1.4. Threat of new entrants
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political & Legal Landscape
    • 3.3.2.2. Economic and Social Landscape
    • 3.3.2.3. Technological landscape

Chapter 4. U.S. Breast Reconstruction Market: Product Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. U.S. Breast Reconstruction Market Product Movement Analysis
• 4.3. U.S. Breast Reconstruction Market Size & Trend Analysis, by Product, 2018 to 2030 (USD Million)
• 4.4. Implants
  • 4.4.1. Implants Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.4.2. Silicone Breasts Implants
    • 4.4.2.1. Silicone Breasts Implants Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.4.3. Saline Breasts Implants
    • 4.4.3.1. Saline Breasts Implants Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.5. Tissue Expander
  • 4.5.1. Tissue Expander Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.5.2. Saline Expander
    • 4.5.2.1. Saline Expander Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.5.3. Air Tissue Expander
    • 4.5.3.1. Air Tissue Expander Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.6. Acellular Dermal Matrix
  • 4.6.1. Acellular Dermal Matrix Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. U.S. Breast Reconstruction Market: Shape Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. U.S. Breast Reconstruction Market Shape Movement Analysis
• 5.3. U.S. Breast Reconstruction Market Size & Trend Analysis, by Shape, 2018 to 2030 (USD Million)
• 5.4. Round
  • 5.4.1. Round Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.5. Anatomical
  • 5.5.1. Anatomical Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. U.S. Breast Reconstruction Market: End Use Estimates & Trend Analysis

• 6.1. Segment Dashboard
• 6.2. U.S. Breast Reconstruction Market End Use Movement Analysis
• 6.3. U.S. Breast Reconstruction Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
• 6.4. Hospitals
  • 6.4.1. Hospitals Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.5. Cosmetology Clinics
  • 6.5.1. Cosmetology Clinics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.6. Ambulatory Surgery Centers
  • 6.6.1. Ambulatory Surgery Centers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Competitive Landscape

• 7.1. Market Participant Categorization
• 7.2. Key Company Profiles
  • 7.2.1. Mentor Medical Systems (Johnson & Johnson)
    • 7.2.1.1. Company Overview
    • 7.2.1.2. Financial Performance
    • 7.2.1.3. Service Benchmarking
    • 7.2.1.4. Strategic Initiatives
  • 7.2.2. Allergan, Inc. (AbbVie)
    • 7.2.2.1. Company Overview
    • 7.2.2.2. Financial Performance
    • 7.2.2.3. Service Benchmarking
    • 7.2.2.4. Strategic Initiatives
  • 7.2.3. Sientra, Inc. (Acquired by Tiger Aesthetics Medical, LLC)
    • 7.2.3.1. Company Overview
    • 7.2.3.2. Financial Performance
    • 7.2.3.3. Service Benchmarking
    • 7.2.3.4. Strategic Initiatives
  • 7.2.4. Ideal Implant, Inc. (Bimini Health Tech.)
    • 7.2.4.1. Company Overview
    • 7.2.4.2. Financial Performance
    • 7.2.4.3. Service Benchmarking
    • 7.2.4.4. Strategic Initiatives
  • 7.2.5. Establishment Labs
    • 7.2.5.1. Company Overview
    • 7.2.5.2. Financial Performance
    • 7.2.5.3. Service Benchmarking
    • 7.2.5.4. Strategic Initiatives
  • 7.2.6. RTI Surgical
    • 7.2.6.1. Company Overview
    • 7.2.6.2. Financial Performance
    • 7.2.6.3. Service Benchmarking
    • 7.2.6.4. Strategic Initiatives
  • 7.2.7. Integra LifeSciences Corporation
    • 7.2.7.1. Company Overview
    • 7.2.7.2. Financial Performance
    • 7.2.7.3. Service Benchmarking
    • 7.2.7.4. Strategic Initiatives